NCM
BIIB icon

Northstar Capital Management’s Biogen BIIB Stock Holding History

Northstar Capital Management’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		$194K Hold
832
– – 0.17% 42
2019
Q2 		$195K Sell
832
-1,114
-57% -$257K 0.17% 41
2019
Q1 		$460K Buy
1,946
+1,475
+313% +$464K 0.42% 38
2018
Q4 		$142K Sell
471
-980
-68% -$313K 0.15% 42
2018
Q3 		$513K Buy
+1,451
New +$500K 0.41% 37

Other funds holding BIIB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Northstar Capital Management's BIIB Position: Q3 2019 in Review

Northstar Capital Management held its Biogen (BIIB) position steady in Q3 2019 at 832 shares worth $194K. The position accounts for 0.17% of the portfolio, ranked #42.

Northstar Capital Management first reported a position in BIIB in Q3 2018 and has held it in 5 quarters since. The position peaked at $513K in Q3 2018. 989 funds tracked by Wall St. Rank hold BIIB as of Q3 2019.

  • Northstar Capital Management held 832 shares of Biogen worth $194K as of Q3 2019.
  • Northstar Capital Management left its Biogen share count unchanged in Q3 2019.
  • Biogen made up 0.17% of Northstar Capital Management's portfolio in Q3 2019, its #42 holding.
  • Northstar Capital Management first reported a position in Biogen in Q3 2018 and has held it in 5 quarters since.
  • Northstar Capital Management's Biogen position peaked at $513K in Q3 2018.
  • 989 funds tracked by Wall St. Rank held Biogen as of Q3 2019.

Based on Northstar Capital Management's 13F filing for Q3 2019, filed 7 Nov 2019.